Treatment Strategies for Deficiency of Adenosine Deaminase 2Amanda K. Ombrello, Daniel L. Kastner, Natalie Deuitch et al.|New England Journal of Medicine|2019Cited by 195
A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high‐titer ABO antibodiesKaren Quillen, Willy A. Flegel, Sherry L. Sheldon et al.|Transfusion|2010Cited by 71
<i>DARC</i>alleles and Duffy phenotypes in African AmericansP. Schmid, Willy A. Flegel, Kanaeko R. Ravenell et al.|Transfusion|2011Cited by 36
The deficiency of adenosine deaminase type 2-results of therapeutic interventionAmanda K. Ombrello, Daniel L. Kastner, Deborah L. Stone et al.|Pediatric Rheumatology|2015Cited by 33
The<i>DAU</i>cluster: a comparative analysis of 18<i>RHD</i>alleles, some forming partial D antigensKshitij Srivastava, Willy A. Flegel, Helene Polin et al.|Transfusion|2016Cited by 23